Načítá se...
Antiangiogenic therapies in ovarian cancer
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the formation and progression of ovarian cancer. Several well-designed phase II and III trials studied the efficacy of antiangiogenic agents in advanced ovarian cancer. The results of these trials demonstrated significantly...
Uloženo v:
| Vydáno v: | Memo |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Vienna
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045478/ https://ncbi.nlm.nih.gov/pubmed/27752291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0282-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|